spacer
home > pmps > spring 2017 > partial to particles
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Partial to Particles

Dry powder inhalers (DPIs) are almost exclusively passive devices, relying on the energy supplied by the inhaling patient for dose dispersion. Consequently, their designs are crucial in determining the extent to which this limited energy supply aerosolises the formulation to a respirable particle size. With growing focus on particles towards the finer end of the size distribution, achieving consistent and effective dispersion with any given inhalation profile is becoming increasingly important.

The incorporation of a breath-actuated mechanism (BAM) has been shown to enhance the dispersion performance of DPIs. It works by inhibiting the release of the dose until the pressure drop across the device reaches a certain value, thereby promoting highly energetic dispersion and efficient delivery.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr David Lewis is Head of Laboratory at Chiesi’s Research Centre in Chippenham, UK, which he established in July 2009. He holds a BSc in Physics as well as an MSc and PhD in Aerosol Science from the University of Essex, UK. David has authored over 130 research publications within the fields of pharmaceutics, analytical chemistry and aerosol science, and is co-inventor of 30 patents relating to pressurised MDI formulations and devices.

After graduating from the University of Southampton, UK, Alan Tweedie worked for a year as a Quality Control Chemist at a UK biotechnology company. He then moved to Bristol, where he joined Vectura, a pharma firm specialising in inhalation therapy. As part of an early-stage feasibility team, Alan was involved in the manufacture and analysis of dry powder formulations, discovering a particular interest in the interactions that exist between the device and formulation. In 2011, he started working for Chiesi at the Chippenham Research Centre.

Francesca Mason graduated from the University of Bradford, UK, in 2010 with a degree in Chemistry, Pharmaceuticals and Forensic Science. She joined Chiesi in 2011 at the Chippenham Research Centre and has now been a Scientist for more than five years. Francesca has predominately worked within the atomisation team involved in creating novel and innovative formulation and technology platforms for inhaled drug delivery.
spacer
Dr David Lewis
spacer
spacer
spacer
Alan Tweedle
spacer
spacer
spacer
Francesca Mason
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ASPIRE International Conference 2018: Pre-registration now open!

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 
Industry Events

LogiMed 2017

18-19 October 2017, Hyperion Hotel, Hamburg

Taking place 18-19th October in Hamburg, LogiMed is Europe’s only dedicated medical device supply chain event bringing together over 150 Medical Device Supply Chain Professionals to network with. With a greater focus on customer collaboration and digital transformation this year’s LogiMed delivers real insights on inventory visibility, supply chain planning, global logistics and digitalization.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement